| Statement |
1.Name and nature of the underlying assets (if preferred shares, the terms and conditions
of issuance shall also be indicated, e.g., dividend yield, etc.):
Common shares of Corpus Christi Polymers, LLC
2.Date of occurrence of the event:2022/01/26~2022/06/02
3.Amount, unit price, and total monetary amount of the transaction:
Transaction volume: N/A Price per unit: N/A Total purchase price: US$ 10,582,569
4.Trading counterparty and its relationship with the Company (if the trading counterparty
is a natural person and furthermore is not a related party of the Company, the name of
the trading counterparty is not required to be disclosed):
Trading counterpart : Corpus Christi Polymers, LLC
Relationship with the company : Equity method investee
5.Where the trading counterparty is a related party, announcement shall also be made of
the reason for choosing the related party as trading counterparty and the identity of
the previous owner, its relationship with the Company and the trading counterparty,
and the previous date and monetary amount of transfer: Capital injection / NIL
6.Where an owner of the underlying assets within the past five years has been a related
party of the Company, the announcement shall also include the date and price of
acquisition and disposal by the related party, and its relationship with the Company
at the time of the transaction:N/A
7.Matters related to the current disposal of creditors' rights (including types of
collaterals of the disposed creditor’s rights; if creditor's rights over a related party,
announcement shall be made of the name of the related party and the book amount of
the creditor's rights, currently being disposed of, over such related party):N/A
8.Profit or loss from the disposal (not applicable in cases of acquisition of securities)
(those with deferral should provide a table explaining recognition):N/A
9.Terms of delivery or payment (including payment period and monetary amount), restrictive
covenants in the contract, and other important terms and conditions:Cash / NIL / NIL
10.The manner of deciding on this transaction (such as invitation to tender, price comparison,
or price negotiation), the reference basis for the decision on price,
and the decision-making unit: Capital injection / Capital injection / The BOD
11.Net worth per share of the Company's underlying securities acquired or disposed of:N/A
12.Cumulative no.of shares held (including the current transaction), their monetary amount,
shareholding percentage, and status of any restriction of rights (e.g., pledges),
as of the present moment: N/A / NT$ 12,637,380,739 / 33.33% / NIL
13.Current ratio of securities investment (including the current trade, as listed in article 3
of Regulations Governing the Acquisition and Disposal of Assets by Public Companies) to the
total assets and equity attributable to owners of the parent as shown in the most recent
financial statement and working capital as shown in the most recent financial statement as
of the present:
Current ratio to total assets: 5.45%
Current ratio to shareholders’ equity: 8.82%
The operating capital as shown in the most recent financial statement: NT$ 10,815,757,000
14.Broker and broker's fee:N/A
15.Concrete purpose or use of the acquisition or disposal: To increase investment in the U.S.
16.Any dissenting opinions of directors to the present transaction:NIL
17.Whether the counterparty of the current transaction is a related party:Yes
18.Date of the board of directors resolution:2022/01/26~2022/06/02
19.Date of ratification by supervisors or approval by the Audit Committee:NA
20.Whether the CPA issued an unreasonable opinion regarding the current transaction:No
21.Name of the CPA firm:Reanda M Y Wu & Co., CPAs
22.Name of the CPA:M.Y. Wu
23.Practice certificate number of the CPA:
Order No. Financial-Supervisory-Securities-Auditing-1000036796 of the
Financial Supervisory Commission
24.Whether the transaction involved in change of business model:No
25.Details on change of business model:N/A
26.Details on transactions with the counterparty for the past year and the expected coming year:N/A
27.Source of funds:N/A
28.Any other matters that need to be specified:NIL
|
